Market research
003060.KO Aprogen pharmaceuticals,Inc
KO KRW Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 25B
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- -0.19
Community
Investor discussion
1 comment
Sign in to join the 003060.KO discussion.
5 years, 4 months ago
Aprogen pharmaceuticals,Inc is currently in a long term downtrend where the price is trading 0.9% below its 200 day moving average.
From a valuation standpoint, the stock is 19.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.9.
Aprogen pharmaceuticals,Inc's total revenue sank by 14.7% to $13B since the same quarter in the previous year.
Its net income has increased by 70.9% to $-850M since the same quarter in the previous year.
Finally, its free cash flow grew by 2211.5% to $4B since the same quarter in the previous year.
Based on the above factors, Aprogen pharmaceuticals,Inc gets an overall score of 3/5.